Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Zilembo

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Drugs & Aging|December 3, 1999
Aromatase inhibitors in the treatment of postmenopausal breast cancerE Bajetta, N Zilembo, E Bichisao
Tumori|March 1, 1995
Second-generation aromatase inhibitorsE Bajetta, N Zilembo, C Noberasco
Tumori|December 31, 1993
Medical treatment of neuroendocrine tumorsE Bajetta, M Di Bartolomeo, N Zilembo, et al.
International Journal of Oncology|May 17, 2011
Systemic treatment of advanced malignant-melanoma (review)F Debraud, E Bajetta, M Zampino, et al.
Critical Reviews in Oncology/Hematology|March 29, 2000
Steroidal aromatase inhibitors in elderly patientsE Bajetta, N Zilembo, E Bichisao, et al.
Oncology Reports|May 21, 2011
Hormonal-therapy in patients with stage-iv breast-cancer at diagnosisN Zilembo, E Bajetta, C Noberasco, et al.
Cancer Treatment Reviews|April 1, 1993
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapyE Bajetta, N Zilembo, R Buzzoni, et al.
Tumori|August 31, 1992
Reversal of resistance to doxifluridine and fluorouracil in metastatic colorectal cancer: the role of high-dose folinic acidM Colleoni, E Bajetta, F de Braud, et al.
Oncology Reports|May 25, 2011
Chemotherapy of advanced malignant-melanoma (review)F Debraud, E Bajetta, M Zampino, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
[131I]metaiodobenzylguanidine therapy in carcinoid tumorsM R Castellani, M Di Bartolomeo, L Maffioli, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Drugs & Aging|December 3, 1999
Aromatase inhibitors in the treatment of postmenopausal breast cancerE Bajetta, N Zilembo, E Bichisao
Tumori|March 1, 1995
Second-generation aromatase inhibitorsE Bajetta, N Zilembo, C Noberasco
Tumori|December 31, 1993
Medical treatment of neuroendocrine tumorsE Bajetta, M Di Bartolomeo, N Zilembo, et al.
International Journal of Oncology|May 17, 2011
Systemic treatment of advanced malignant-melanoma (review)F Debraud, E Bajetta, M Zampino, et al.
Critical Reviews in Oncology/Hematology|March 29, 2000
Steroidal aromatase inhibitors in elderly patientsE Bajetta, N Zilembo, E Bichisao, et al.
Oncology Reports|May 21, 2011
Hormonal-therapy in patients with stage-iv breast-cancer at diagnosisN Zilembo, E Bajetta, C Noberasco, et al.
Cancer Treatment Reviews|April 1, 1993
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapyE Bajetta, N Zilembo, R Buzzoni, et al.
Tumori|August 31, 1992
Reversal of resistance to doxifluridine and fluorouracil in metastatic colorectal cancer: the role of high-dose folinic acidM Colleoni, E Bajetta, F de Braud, et al.
Oncology Reports|May 25, 2011
Chemotherapy of advanced malignant-melanoma (review)F Debraud, E Bajetta, M Zampino, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
[131I]metaiodobenzylguanidine therapy in carcinoid tumorsM R Castellani, M Di Bartolomeo, L Maffioli, et al.
Pageof 6